AR034046A1 - Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostata - Google Patents
Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostataInfo
- Publication number
- AR034046A1 AR034046A1 ARP020101934A ARP020101934A AR034046A1 AR 034046 A1 AR034046 A1 AR 034046A1 AR P020101934 A ARP020101934 A AR P020101934A AR P020101934 A ARP020101934 A AR P020101934A AR 034046 A1 AR034046 A1 AR 034046A1
- Authority
- AR
- Argentina
- Prior art keywords
- diseases
- prostate
- compositions
- antiprogestines
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Métodos y usos para tratar enfermedades de la próstata, en particular cáncer de próstata e hiperplasia benigna de la próstata, en mamíferos macho, como antiprogestinas, en particular, la antiprogestina 11beta-(4-acetilfenil)-17beta-hidroxi-17alfa-(1,1,2,2,2-pentafluorofenil)-estra-4,9-dien-3-ona, o un derivado o análogo de la misma aceptable para uso farmacéutico. Composiciones farmacéuticas que comprenden dicha antiprogestina.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01250185 | 2001-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR034046A1 true AR034046A1 (es) | 2004-01-21 |
Family
ID=8181589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP020101934A AR034046A1 (es) | 2001-05-25 | 2002-05-24 | Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostata |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1392399A1 (es) |
JP (2) | JP2004531561A (es) |
AR (1) | AR034046A1 (es) |
PE (1) | PE20021138A1 (es) |
UY (1) | UY27301A1 (es) |
WO (1) | WO2002094379A1 (es) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3733478A1 (de) * | 1987-10-01 | 1989-04-13 | Schering Ag | Antigestagen- und antioestrogenwirksame verbindungen zur geburtseinleitung und zum schwangerschaftsabbruch sowie zur behandlung gynaekologischer stoerungen und hormonabhaengiger tumore |
DE4039561A1 (de) * | 1990-12-07 | 1992-07-09 | Schering Ag | Verwendung von antigestagenen zur herstellung von arzneimitteln |
DE4318371A1 (de) * | 1993-05-28 | 1994-12-01 | Schering Ag | Mittel, enthaltend eine Verbindung mit antiandrogener sowie eine Verbindung mit kompetitiver, progesteronantagonistischer Wirkung |
DE19706061A1 (de) * | 1997-02-07 | 1998-08-13 | Schering Ag | Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette |
DE60121980T2 (de) * | 2000-10-18 | 2007-03-01 | Schering Ag | Verwendung von 11beta-(4-acetylphenyl)-17beta-hydroxy-17alpha-(1,1,2,2-pentafluoroethyl)estra-4,9-dien-3-on zur herstellung eines medikaments zur behandlung von brust-, eierstock-, endometrium-krebs, myelom und meningiom |
EP1328276B1 (en) * | 2000-10-18 | 2005-11-23 | Schering Aktiengesellschaft | Use of antiprogestins for prophylaxis and treatment of hormone-dependent diseases |
-
2002
- 2002-05-21 UY UY27301A patent/UY27301A1/es not_active Application Discontinuation
- 2002-05-24 PE PE2002000438A patent/PE20021138A1/es not_active Application Discontinuation
- 2002-05-24 AR ARP020101934A patent/AR034046A1/es not_active Application Discontinuation
- 2002-05-27 WO PCT/EP2002/005819 patent/WO2002094379A1/en active Application Filing
- 2002-05-27 EP EP02745322A patent/EP1392399A1/en not_active Ceased
- 2002-05-27 JP JP2002591093A patent/JP2004531561A/ja active Pending
-
2009
- 2009-12-10 JP JP2009280715A patent/JP2010077157A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
UY27301A1 (es) | 2003-02-28 |
WO2002094379A1 (en) | 2002-11-28 |
JP2010077157A (ja) | 2010-04-08 |
PE20021138A1 (es) | 2003-01-11 |
EP1392399A1 (en) | 2004-03-03 |
JP2004531561A (ja) | 2004-10-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ285159A (en) | Treatment of benign prostatic hyperplasia, endometriosis, prostatic carcinoma and obesity by administration of droloxifene | |
ES2133270T3 (es) | Terapia de combinacion para la profilaxis y/o el tratamiento de hiperplasia prostatica benigna. | |
BR0210056A (pt) | composições e métodos para tratamento de hiperplasia | |
AR028296A1 (es) | Metodos sinergisticos y composiciones para el tratamiento del cancer | |
ATE556706T1 (de) | Fettalkohol-arzneimittel-konjugate | |
CU23213A3 (es) | Difenilureas sustituidas con omega-carboxiarilo como inhibidores de raf quinasa | |
UY26929A1 (es) | Polipéptidos antiangiogénicos y métodos para inhibir la angiogénesis | |
BRPI0406796A (pt) | Métodos para tratar hipertrofia prostática benigna, para reduzir um sintoma associado com a mesma, para reduzir o tamanho da próstata em um indivìduo humano e para profilaxia de bhp, composição farmacêutica oral de dose unitária, e, uso de lonidamina ou um análogo de lonidamina | |
BRPI0207961A8 (pt) | Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos. | |
CY1104981T1 (el) | Χρηση των αντιπρογεστερονων για προληψη και αντιμετωπιση των εξαρτωμενων απο ορμονες ασθενειων | |
ES2157601T3 (es) | Uso de agentes anti-microtubulos para tratar o prevenir la esclerosis multiple. | |
BR9715022A (pt) | Método para tratar de doenças prostáticas usando formulações de vitamina d por liberação sistemática e/ou prolongada | |
PA8481501A1 (es) | 4-carboxiamino-2-metil-1,2,3,4-tetrahidroquinolinas | |
HUP0100586A2 (hu) | Alsó húgyvezetéki tünetek kezelésére alkalmas gyógyászati készítmények | |
PT1420801E (pt) | Utilização de fucanos no tratamento de adesões, artrite e psoríase | |
BR0318278A (pt) | compostos de éter aminocicloexìlico e usos dos mesmo | |
AR012626A1 (es) | Una composicion farmaeutica que comprende un derivado o análogo de leptina como inhibidor de la proliferacion de células de tumor y el uso de dicha composicion farmaceutica para la manufactura de medicamento para el tratamiento de tumores | |
BR0111630A (pt) | Espiral para inseto | |
BR0108728A (pt) | Combinação farmacêutica terapêutica, e, método para tratar um c ncer. | |
PT912185E (pt) | Novas formulacoes farmaceuticas contendo derivados de ester nitrato de esteroides proveitosos como farmacos anti-inflamatorios | |
ATE327973T1 (de) | Polyamin-analoge als cytotoxische wirkstoffe | |
AR034046A1 (es) | Uso y composiciones de antiprogestinas para el tratamiento de enfermedades de la prostata | |
AR029451A1 (es) | Una composicion para su uso en la terapia del cancer de mamas en seres humanos y un producto para su uso en dicha terapia | |
ES2163634T3 (es) | Benzopiranos y composiciones farmaceuticas que les contienen. | |
NO952601L (no) | Oligonukleotider for inhibering av ekspresjon av isoprenylprotein-transferaser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |